Key result
Microinjection of the AT1 receptor antagonist losartan into the paraventricular nucleus entirely prevented the hyperthermia-induced 48% decrease in renal blood flow in anesthetized rats.
Why the study?
Does AT1 receptor blockade with losartan in the paraventricular nucleus prevent hyperthermia-induced reduction of renal blood flow in rats?
Does AT1 receptor blockade with losartan in the paraventricular nucleus prevent hyperthermia-induced reduction of renal blood flow in rats?
Endogenous angiotensin II acts on AT1 receptors in the paraventricular nucleus to mediate the reflex reduction in renal blood flow induced by hyperthermia in rats.
AT1 blockade in the PVN prevents hyperthermia-induced renal hypoperfusion in rats; hypothesis-generating for central angiotensinergic control, untested in humans.
Increasing body core temperature reflexly decreases renal blood flow (RBF), and the hypothalamic paraventricular nucleus (PVN) plays an essential role in this response. ANG II in the brain is involved in the cardiovascular responses to hyperthermia, and ANG II receptors are highly concentrated in the PVN. The present study investigated whether ANG II in the PVN contributes to the cardiovascular responses elicited by hyperthermia. Rats anesthetized with urethane (1-1.4 g/kg iv) were microinjected bilaterally into the PVN (100 nl/side) with saline (n = 5) or losartan (1 nmol/100 nl) (n = 7), an AT1 receptor antagonist. Body core temperature was then elevated from 37°C to 41°C and blood pressure (BP), heart rate (HR), RBF, and renal vascular conductance (RVC) were monitored. In separate groups losartan (n = 4) or saline (n = 4) was microinjected into the PVN, but body core temperature was not elevated. Increasing body core temperature in control rats elicited significant decreases in RBF (-48 ± 5% from a resting level of 14.3 ± 1.4 ml/min) and MVC (-40 ± 4% from a resting level of 0.128 ± 0.013 ml/min·mmHg), and these effects were entirely prevented by pretreatment with losartan. In rats in which body core temperature was not altered, losartan microinjected into the PVN had no significant effects on these variables. The results suggest that endogenous ANG II acts on AT1 receptors in the PVN to mediate the reduction in RBF induced by hyperthermia.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2010) studied Hyperthermia-induced cardiovascular responses (n=20). Losartan microinjected into the paraventricular nucleus vs. Saline was evaluated on Change in renal blood flow (RBF). Microinjection of the AT1 receptor antagonist losartan into the paraventricular nucleus entirely prevented the hyperthermia-induced 48% decrease in renal blood flow in anesthetized rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: